Witnessing RoboCT’s AI Medical Technology Innovation CHS2023 Online Salon
Release time:2023-11-10
Related article
Recently, an online salon with the theme of "Medical Technology Innovation under Digital Transformation" was successfully held. This salon was a warm-up event for the CHS 2023 The 8th China Big Health Industry Upgrade Summit. At the salon, ZHANG Jiyu, co-founder of RoboCT Technology, and other company representatives shared their in-depth insights into the development of AI medical care from the perspectives of their respective businesses segmented tracks and delivered relevant keynote speeches.
With the rapid development of artificial intelligence, the medical and healthcare industry is constantly breaking through traditional service models and undergoing unprecedented changes. Artificial intelligence and big data are accelerating towards the market, serving the entire process of pre-diagnosis, diagnosis, post-diagnosis, and rehabilitation management. To cope with the trend of aging and the high incidence of chronic diseases, rehabilitation, and elderly care continue to receive policy support and market attention. Cloud architecture and the Internet are promoting a new stage of digital medical information construction; AI imaging medical devices for multiple indications are constantly emerging; "Digital Therapy" is advancing into clinical care; Out-of-hospital management such as home and community health management relies on the application of IoT.
In the keynote speech, ZHANG Jiyu, co-founder of RoboCT, shared his thoughts on the application of exoskeleton robotics in the field of rehabilitation and elderly care. The prevalence of stroke in China is high, and 54% of stroke patients have walking problems. There is a huge demand for rehabilitation. The exoskeleton is expected to become an indispensable tool in the rehabilitation market. In response to different rehabilitation needs, RoboCT's rehab exoskeleton mainly solves core problems in three directions: rehabilitation treatment, motion compensation, and mitigating the occurrence of concurrent diseases.
RoboCT hopes to develop exoskeleton technology into one of the future AI medical solutions through "human-machine fusion" and inject it into the needs of life rehabilitation and elderly care to benefit people's livelihood. RoboCT believes that technology does not turn people into useless people, but uses the power of technology to turn people into superhuman.
In 2023, the year when the health industry restarts, the medical industry is facing unprecedented changes and complex challenges. Health companies are maintaining a balance between "change" and "unchanged", evolving and innovating. For the serious and slow-moving medical field, evolutionary innovation is becoming a source of power to promote enterprise development. RoboCT Technology also hopes to maintain its advantages in the fierce market competition and achieve sustainable development, and in the process seize opportunities to achieve further evolution.